well, we can spec all we want, its certainly fun! but the tell will be whether they delay earnings next week? If so, a deal is at least in the works. And, Gilead, with its bad #'s is ripe with cash!
Other targets tho are ICPT, ALKS, MACK, and OPK whence they are approved after manufacturer issues.
Otherwise, this should keep climbing despite pesky shorts trying again.